|

Efgartigimod Alfa Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Vyvgart Hytrulo

Pipeline

Phase 2: 1

Top Sponsors

  • Anastasia Vishnevetsky, MD, MPH1

Indications

  • Optic Neuritis1
  • Multiple Sclerosis1

Boston, Massachusetts1 trial

Efgartigimod for the Treatment of Acute Optic Neuritis

Massachusetts Eye and Ear Infirmary

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.